FluGen
is a Wisconsin-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of influenza viral diseases... Read moreFluGen
is a Wisconsin-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of influenza viral diseases... Read more
News
Jul 15, 2024
Clinical Trials Arena
FluGen: FluGen's intranasal flu vaccine boosts flu shot efficacy
Jul 15, 2024
OINDPnews
FluGen: Phase 1 trial FluGen's M2SR intranasal flu vaccine in elderly demonstrated benefit of coadministration
May 01, 2024
StreetInsider
Press Release: FluGen : BioMedNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Partners with FluGen to Develop First-of-Its-Kind Intranasal Flu Vaccine for Global Distribution
Feb 07, 2023
Drug Discovery and Development
FluGen: Dual defense: FluGen's M2SR vaccine shields against influenza and COVID-19
Nov 09, 2022
StreetInsider
Press Release: FluGen : New Data Published in the Journal of Infectious Diseases Demonstrate FluGen's M2SR Vaccine Candidate Substantially Enhances Mucosal & Serum Antibodies Against Drifted Influenza Strains
Sep 07, 2022
OINDPnews
FluGen: FluGen announces progress in age de-escalating trial of M2SR intranasal flu vaccine in children
Jun 22, 2022
FirstWord Pharma
FluGen: FluGen Announces First Subject Dosed in Phase 1b Clinical Trial of its Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults
Jan 05, 2022
PR Newswire
Press Release: FluGen : FluGen to Present at the 40th Annual J.P. Morgan Healthcare Conference
Sep 21, 2021
Contract Pharma
FluGen: Naobios to Manufacture FluGen's M2SR Flu Vax Candidate
Aug 03, 2021
Drug Discovery and Development
FluGen: Intranasal FluGen vaccine offers protection in human challenge study
FluGen Competitors
1
2
3
4
5
6
7
8
9
10